Intra-Cellular Therapies
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
115.2036.8218.8611.70
Price/Sales ratio
11.608.045.854.33
Earnings per Share (EPS)
$1.14$3.58$6.99$11.26

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-16.47-18.48-5.60-6.83-4.01-12.81-9.85-14.96-19.42-49.16-21.54-12.81
Price/Sales ratio
875.9221.20K1.97K2.72KN/A31.23K99.3152.0419.9714.7822.1531.23K
Price/Book Value ratio
4.194.061.731.471.969.703.4010.177.5811.618.411.96
Price/Cash Flow ratio
-22.17-18.93-7.15-8.30-5.27-14.79-9.72-16.38-18.42-55.29-20.43-14.79
Price/Free Cash Flow ratio
-22.16-18.78-7.14-8.23-5.25-14.71-9.71-16.36-18.36-55.17-20.37-14.71
Price/Earnings Growth ratio
0.52-0.100.740.32-0.112.27-0.48-1.790.871.06-0.972.27
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-3576.82%-52.82%-28273.43%-32205.55%N/A-687.15%91.58%90.16%91.79%92.73%91.79%91.79%
Operating Profit Margin
-5367.51%-115815.85%-35759.95%-41832.64%N/A-254090.45%-1026.27%-349.64%-105.81%-34.32%-105.81%-105.81%
Pretax Profit Margin
-5316.09%-114696.75%-34883.54%-40203.16%N/A-243711.04%-1007.47%-347.72%-102.85%-29.94%-102.85%-102.85%
Net Profit Margin
-5316.37%-114698.50%-35205.79%-39771.64%N/A-243713.68%-1007.53%-347.73%-102.85%-30.07%-102.85%-102.85%
Effective Tax Rate
-0.00%-0.00%-0.92%1.07%-0.00%-0.00%-0.00%-0.00%-0.00%-0.45%-0.00%-0.00%
Return on Assets
-23.40%-21.64%-29.93%-20.73%-43.42%-58.80%-31.64%-57.99%-33.95%-19.17%-33.95%-43.42%
Return On Equity
-25.45%-22.00%-31.00%-21.51%-48.82%-75.75%-34.55%-67.99%-39.05%-23.61%-35.88%-48.82%
Return on Capital Employed
-25.70%-22.14%-31.25%-22.48%-50.56%-71.64%-33.98%-65.43%-39.25%-26.35%-39.25%-50.56%
Liquidity Ratios
Current Ratio
12.4077.1536.8533.029.796.3518.74N/AN/AN/A8.866.35
Quick Ratio
12.4077.1536.8533.029.796.3518.558.608.575.318.016.35
Cash ratio
5.807.524.612.651.512.971.621.731.781.191.781.51
Days of Sales Outstanding
32.62122.48104.12N/AN/AN/A174.3890.03110.1589.61110.15N/A
Days of Inventory outstanding
N/A0.000.00N/AN/AN/A1.35K361.07427.08125.97427.08N/A
Operating Cycle
32.62122.48104.12N/AN/AN/A1.53K451.11537.23215.59454.24N/A
Days of Payables Outstanding
35.294.26K14.6028.3713.82K5.68K1.05K394.81185.59123.86185.595.68K
Cash Conversion Cycle
-2.67-4.14K89.51-28.37N/A-5.68K473.8056.29351.6491.7229.86-5.68K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A38.110.000.000.13N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A44.680.000.000.15N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.97N/AN/A0.02N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.970.000.000.02N/A
Interest Coverage Ratio
-4.38KN/A-3.21KN/AN/AN/AN/AN/AN/AN/A-35.74N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-0.01-59.16-34.38-13.48N/A
Company Equity Multiplier
1.081.011.031.031.121.281.091.171.151.231.151.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-39.50-1.11K-275.95-327.41N/A-2.11K-10.21-3.17-1.08-0.26-1.08-1.08
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.001.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-0.01-59.16-34.38-13.48N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-59.16-34.38-59.16N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A